nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—SLCO1B1—Sulfasalazine—Crohn's disease	0.177	0.329	CbGbCtD
Ezetimibe—ABCC2—Sulfasalazine—Crohn's disease	0.155	0.289	CbGbCtD
Ezetimibe—ABCG2—Sulfasalazine—Crohn's disease	0.14	0.261	CbGbCtD
Ezetimibe—ABCB1—Prednisone—Crohn's disease	0.0405	0.0753	CbGbCtD
Ezetimibe—ANPEP—bile—Crohn's disease	0.0307	0.138	CbGeAlD
Ezetimibe—ABCG5—gall bladder—Crohn's disease	0.0276	0.125	CbGeAlD
Ezetimibe—ABCG8—gall bladder—Crohn's disease	0.0246	0.111	CbGeAlD
Ezetimibe—CYP3A4—Prednisone—Crohn's disease	0.0242	0.0451	CbGbCtD
Ezetimibe—ABCC2—bile—Crohn's disease	0.0122	0.0552	CbGeAlD
Ezetimibe—ABCG5—digestive system—Crohn's disease	0.0109	0.0491	CbGeAlD
Ezetimibe—UGT2B15—gall bladder—Crohn's disease	0.0103	0.0467	CbGeAlD
Ezetimibe—NPC1L1—digestive system—Crohn's disease	0.0102	0.0462	CbGeAlD
Ezetimibe—ABCG8—digestive system—Crohn's disease	0.00969	0.0438	CbGeAlD
Ezetimibe—SOAT1—gall bladder—Crohn's disease	0.0089	0.0402	CbGeAlD
Ezetimibe—ANPEP—gall bladder—Crohn's disease	0.00851	0.0384	CbGeAlD
Ezetimibe—Lupus-like syndrome—Mesalazine—Crohn's disease	0.00777	0.0389	CcSEcCtD
Ezetimibe—Red blood cell sedimentation rate increased—Mesalazine—Crohn's disease	0.0068	0.0341	CcSEcCtD
Ezetimibe—ANPEP—Glutathione metabolism—GPX4—Crohn's disease	0.00482	0.115	CbGpPWpGaD
Ezetimibe—SOAT1—smooth muscle tissue—Crohn's disease	0.00443	0.02	CbGeAlD
Ezetimibe—ANPEP—epithelium—Crohn's disease	0.0044	0.0199	CbGeAlD
Ezetimibe—UGT1A3—digestive system—Crohn's disease	0.00433	0.0196	CbGeAlD
Ezetimibe—ANPEP—smooth muscle tissue—Crohn's disease	0.00424	0.0192	CbGeAlD
Ezetimibe—ABCC3—gall bladder—Crohn's disease	0.00424	0.0192	CbGeAlD
Ezetimibe—ANPEP—skin of body—Crohn's disease	0.00419	0.0189	CbGeAlD
Ezetimibe—UGT2B15—digestive system—Crohn's disease	0.00407	0.0184	CbGeAlD
Ezetimibe—SOAT1—mammalian vulva—Crohn's disease	0.00399	0.018	CbGeAlD
Ezetimibe—ANPEP—mammalian vulva—Crohn's disease	0.00382	0.0172	CbGeAlD
Ezetimibe—Cognitive impairment—Prednisone—Crohn's disease	0.00371	0.0186	CcSEcCtD
Ezetimibe—SOAT1—digestive system—Crohn's disease	0.0035	0.0158	CbGeAlD
Ezetimibe—ANPEP—lymphoid tissue—Crohn's disease	0.00339	0.0153	CbGeAlD
Ezetimibe—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00337	0.0169	CcSEcCtD
Ezetimibe—ANPEP—digestive system—Crohn's disease	0.00335	0.0151	CbGeAlD
Ezetimibe—Memory loss—Prednisone—Crohn's disease	0.0033	0.0165	CcSEcCtD
Ezetimibe—Foetor hepaticus—Mesalazine—Crohn's disease	0.00323	0.0162	CcSEcCtD
Ezetimibe—Cholecystitis—Mesalazine—Crohn's disease	0.00319	0.016	CcSEcCtD
Ezetimibe—Transaminases increased—Mesalazine—Crohn's disease	0.00301	0.0151	CcSEcCtD
Ezetimibe—Cholelithiasis—Mesalazine—Crohn's disease	0.00294	0.0147	CcSEcCtD
Ezetimibe—Interstitial lung disease—Azathioprine—Crohn's disease	0.00284	0.0142	CcSEcCtD
Ezetimibe—Liver disorder—Mesalazine—Crohn's disease	0.00269	0.0135	CcSEcCtD
Ezetimibe—Interstitial lung disease—Mesalazine—Crohn's disease	0.00259	0.013	CcSEcCtD
Ezetimibe—UGT2B7—digestive system—Crohn's disease	0.00249	0.0112	CbGeAlD
Ezetimibe—Neoplasm malignant—Azathioprine—Crohn's disease	0.00235	0.0118	CcSEcCtD
Ezetimibe—Cognitive disorder—Prednisone—Crohn's disease	0.00224	0.0112	CcSEcCtD
Ezetimibe—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.00223	0.0111	CcSEcCtD
Ezetimibe—Breast disorder—Mercaptopurine—Crohn's disease	0.00221	0.0111	CcSEcCtD
Ezetimibe—UGT1A1—digestive system—Crohn's disease	0.00211	0.00955	CbGeAlD
Ezetimibe—Pancreatitis—Mercaptopurine—Crohn's disease	0.00208	0.0104	CcSEcCtD
Ezetimibe—Vasculitis—Azathioprine—Crohn's disease	0.00206	0.0103	CcSEcCtD
Ezetimibe—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00203	0.0484	CbGpPWpGaD
Ezetimibe—Bone disorder—Mesalazine—Crohn's disease	0.00203	0.0102	CcSEcCtD
Ezetimibe—Hepatocellular injury—Azathioprine—Crohn's disease	0.00201	0.0101	CcSEcCtD
Ezetimibe—SOAT1—lymph node—Crohn's disease	0.002	0.00903	CbGeAlD
Ezetimibe—ANPEP—lymph node—Crohn's disease	0.00191	0.00864	CbGeAlD
Ezetimibe—Neck pain—Mesalazine—Crohn's disease	0.00185	0.00928	CcSEcCtD
Ezetimibe—Hepatocellular injury—Mesalazine—Crohn's disease	0.00183	0.00917	CcSEcCtD
Ezetimibe—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.00183	0.00917	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00178	0.00894	CcSEcCtD
Ezetimibe—SLCO1B1—digestive system—Crohn's disease	0.00176	0.00795	CbGeAlD
Ezetimibe—ABCC3—digestive system—Crohn's disease	0.00167	0.00754	CbGeAlD
Ezetimibe—Hepatic failure—Azathioprine—Crohn's disease	0.00162	0.00813	CcSEcCtD
Ezetimibe—Immune system disorder—Mercaptopurine—Crohn's disease	0.00153	0.00766	CcSEcCtD
Ezetimibe—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00153	0.00765	CcSEcCtD
Ezetimibe—Photosensitivity—Mesalazine—Crohn's disease	0.00151	0.00758	CcSEcCtD
Ezetimibe—Alopecia—Mercaptopurine—Crohn's disease	0.0015	0.0075	CcSEcCtD
Ezetimibe—Hepatic failure—Mesalazine—Crohn's disease	0.00148	0.00741	CcSEcCtD
Ezetimibe—Malnutrition—Mercaptopurine—Crohn's disease	0.00147	0.00739	CcSEcCtD
Ezetimibe—Myopathy—Prednisone—Crohn's disease	0.00138	0.00692	CcSEcCtD
Ezetimibe—Arthritis—Mesalazine—Crohn's disease	0.00137	0.00685	CcSEcCtD
Ezetimibe—Anaemia—Mercaptopurine—Crohn's disease	0.00136	0.00683	CcSEcCtD
Ezetimibe—ABCC2—digestive system—Crohn's disease	0.00133	0.00603	CbGeAlD
Ezetimibe—ANPEP—C-MYB transcription factor network—MPO—Crohn's disease	0.0013	0.0311	CbGpPWpGaD
Ezetimibe—Arthralgia—Mercaptopurine—Crohn's disease	0.00126	0.00629	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00125	0.00625	CcSEcCtD
Ezetimibe—Pancreatitis—Azathioprine—Crohn's disease	0.00124	0.00619	CcSEcCtD
Ezetimibe—Memory impairment—Prednisone—Crohn's disease	0.00123	0.00618	CcSEcCtD
Ezetimibe—Liver function test abnormal—Mesalazine—Crohn's disease	0.00123	0.00615	CcSEcCtD
Ezetimibe—Breast disorder—Mesalazine—Crohn's disease	0.0012	0.00602	CcSEcCtD
Ezetimibe—Cramp muscle—Mesalazine—Crohn's disease	0.0012	0.00599	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.0012	0.00599	CcSEcCtD
Ezetimibe—Nasopharyngitis—Mesalazine—Crohn's disease	0.00119	0.00595	CcSEcCtD
Ezetimibe—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00118	0.0059	CcSEcCtD
Ezetimibe—Gastritis—Mesalazine—Crohn's disease	0.00118	0.00589	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00117	0.00587	CcSEcCtD
Ezetimibe—Skin disorder—Mercaptopurine—Crohn's disease	0.00117	0.00586	CcSEcCtD
Ezetimibe—Influenza—Mesalazine—Crohn's disease	0.00115	0.00575	CcSEcCtD
Ezetimibe—Eosinophilia—Mesalazine—Crohn's disease	0.00114	0.0057	CcSEcCtD
Ezetimibe—NPC1L1—Lipid and lipoprotein metabolism—ALB—Crohn's disease	0.00113	0.0269	CbGpPWpGaD
Ezetimibe—Pancreatitis—Mesalazine—Crohn's disease	0.00113	0.00564	CcSEcCtD
Ezetimibe—Infestation NOS—Azathioprine—Crohn's disease	0.00112	0.00563	CcSEcCtD
Ezetimibe—Infestation—Azathioprine—Crohn's disease	0.00112	0.00563	CcSEcCtD
Ezetimibe—ABCG2—mammalian vulva—Crohn's disease	0.00111	0.00501	CbGeAlD
Ezetimibe—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0011	0.00549	CcSEcCtD
Ezetimibe—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.0011	0.0261	CbGpPWpGaD
Ezetimibe—Viral infection—Prednisone—Crohn's disease	0.00107	0.00537	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00107	0.00535	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00106	0.00533	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00105	0.00525	CcSEcCtD
Ezetimibe—Decreased appetite—Mercaptopurine—Crohn's disease	0.00105	0.00524	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00104	0.0052	CcSEcCtD
Ezetimibe—Infestation NOS—Mesalazine—Crohn's disease	0.00102	0.00513	CcSEcCtD
Ezetimibe—Infestation—Mesalazine—Crohn's disease	0.00102	0.00513	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Mesalazine—Crohn's disease	0.001	0.00503	CcSEcCtD
Ezetimibe—Jaundice—Mesalazine—Crohn's disease	0.000998	0.005	CcSEcCtD
Ezetimibe—Vasculitis—Prednisone—Crohn's disease	0.000993	0.00497	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—TAB1—Crohn's disease	0.000982	0.0234	CbGpPWpGaD
Ezetimibe—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000969	0.00485	CcSEcCtD
Ezetimibe—Sinusitis—Mesalazine—Crohn's disease	0.000961	0.00481	CcSEcCtD
Ezetimibe—Erythema multiforme—Azathioprine—Crohn's disease	0.000955	0.00478	CcSEcCtD
Ezetimibe—ABCC3—lymph node—Crohn's disease	0.000954	0.00431	CbGeAlD
Ezetimibe—Body temperature increased—Mercaptopurine—Crohn's disease	0.000952	0.00477	CcSEcCtD
Ezetimibe—Hepatitis—Mesalazine—Crohn's disease	0.00092	0.00461	CcSEcCtD
Ezetimibe—Pharyngitis—Mesalazine—Crohn's disease	0.000913	0.00457	CcSEcCtD
Ezetimibe—Immune system disorder—Azathioprine—Crohn's disease	0.000912	0.00457	CcSEcCtD
Ezetimibe—Mediastinal disorder—Azathioprine—Crohn's disease	0.00091	0.00456	CcSEcCtD
Ezetimibe—Oedema peripheral—Mesalazine—Crohn's disease	0.000906	0.00454	CcSEcCtD
Ezetimibe—Connective tissue disorder—Mesalazine—Crohn's disease	0.000904	0.00453	CcSEcCtD
Ezetimibe—Alopecia—Azathioprine—Crohn's disease	0.000892	0.00447	CcSEcCtD
Ezetimibe—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000887	0.00444	CcSEcCtD
Ezetimibe—Erythema multiforme—Mesalazine—Crohn's disease	0.000869	0.00435	CcSEcCtD
Ezetimibe—ABCG8—Lipid and lipoprotein metabolism—ALB—Crohn's disease	0.000856	0.0204	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000847	0.0202	CbGpPWpGaD
Ezetimibe—Angiopathy—Mesalazine—Crohn's disease	0.000834	0.00418	CcSEcCtD
Ezetimibe—Immune system disorder—Mesalazine—Crohn's disease	0.000831	0.00416	CcSEcCtD
Ezetimibe—Mediastinal disorder—Mesalazine—Crohn's disease	0.000829	0.00415	CcSEcCtD
Ezetimibe—ABCG5—Lipid and lipoprotein metabolism—ALB—Crohn's disease	0.000824	0.0197	CbGpPWpGaD
Ezetimibe—Diarrhoea—Mercaptopurine—Crohn's disease	0.000824	0.00412	CcSEcCtD
Ezetimibe—Ill-defined disorder—Azathioprine—Crohn's disease	0.000815	0.00408	CcSEcCtD
Ezetimibe—Alopecia—Mesalazine—Crohn's disease	0.000813	0.00407	CcSEcCtD
Ezetimibe—Anaemia—Azathioprine—Crohn's disease	0.000812	0.00407	CcSEcCtD
Ezetimibe—Mental disorder—Mesalazine—Crohn's disease	0.000806	0.00403	CcSEcCtD
Ezetimibe—Erythema—Mesalazine—Crohn's disease	0.0008	0.00401	CcSEcCtD
Ezetimibe—Malaise—Azathioprine—Crohn's disease	0.000793	0.00397	CcSEcCtD
Ezetimibe—Flatulence—Mesalazine—Crohn's disease	0.000789	0.00395	CcSEcCtD
Ezetimibe—Back pain—Mesalazine—Crohn's disease	0.000774	0.00388	CcSEcCtD
Ezetimibe—Muscle spasms—Mesalazine—Crohn's disease	0.00077	0.00385	CcSEcCtD
Ezetimibe—Vomiting—Mercaptopurine—Crohn's disease	0.000765	0.00383	CcSEcCtD
Ezetimibe—ABCC2—lymph node—Crohn's disease	0.000762	0.00344	CbGeAlD
Ezetimibe—Rash—Mercaptopurine—Crohn's disease	0.000759	0.0038	CcSEcCtD
Ezetimibe—Dermatitis—Mercaptopurine—Crohn's disease	0.000758	0.0038	CcSEcCtD
Ezetimibe—Amnesia—Prednisone—Crohn's disease	0.000749	0.00375	CcSEcCtD
Ezetimibe—Arthralgia—Azathioprine—Crohn's disease	0.000748	0.00375	CcSEcCtD
Ezetimibe—Myalgia—Azathioprine—Crohn's disease	0.000748	0.00375	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—SBSPON—Crohn's disease	0.000744	0.0177	CbGpPWpGaD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000743	0.00372	CcSEcCtD
Ezetimibe—Ill-defined disorder—Mesalazine—Crohn's disease	0.000743	0.00372	CcSEcCtD
Ezetimibe—Anaemia—Mesalazine—Crohn's disease	0.00074	0.00371	CcSEcCtD
Ezetimibe—Discomfort—Azathioprine—Crohn's disease	0.000739	0.0037	CcSEcCtD
Ezetimibe—Angioedema—Mesalazine—Crohn's disease	0.000731	0.00366	CcSEcCtD
Ezetimibe—Malaise—Mesalazine—Crohn's disease	0.000722	0.00362	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00072	0.0172	CbGpPWpGaD
Ezetimibe—Nausea—Mercaptopurine—Crohn's disease	0.000715	0.00358	CcSEcCtD
Ezetimibe—Infection—Azathioprine—Crohn's disease	0.000713	0.00357	CcSEcCtD
Ezetimibe—Palpitations—Mesalazine—Crohn's disease	0.000707	0.00354	CcSEcCtD
Ezetimibe—Thrombocytopenia—Azathioprine—Crohn's disease	0.000702	0.00352	CcSEcCtD
Ezetimibe—Cough—Mesalazine—Crohn's disease	0.000699	0.0035	CcSEcCtD
Ezetimibe—Skin disorder—Azathioprine—Crohn's disease	0.000697	0.00349	CcSEcCtD
Ezetimibe—Hypertension—Mesalazine—Crohn's disease	0.000691	0.00346	CcSEcCtD
Ezetimibe—Chest pain—Mesalazine—Crohn's disease	0.000682	0.00341	CcSEcCtD
Ezetimibe—Arthralgia—Mesalazine—Crohn's disease	0.000682	0.00341	CcSEcCtD
Ezetimibe—Myalgia—Mesalazine—Crohn's disease	0.000682	0.00341	CcSEcCtD
Ezetimibe—CYP3A4—digestive system—Crohn's disease	0.000678	0.00306	CbGeAlD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000677	0.00339	CcSEcCtD
Ezetimibe—Discomfort—Mesalazine—Crohn's disease	0.000673	0.00337	CcSEcCtD
Ezetimibe—Dry mouth—Mesalazine—Crohn's disease	0.000667	0.00334	CcSEcCtD
Ezetimibe—Confusional state—Mesalazine—Crohn's disease	0.000659	0.0033	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000653	0.00327	CcSEcCtD
Ezetimibe—Anaphylactic shock—Mesalazine—Crohn's disease	0.000653	0.00327	CcSEcCtD
Ezetimibe—Infection—Mesalazine—Crohn's disease	0.000649	0.00325	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000642	0.0153	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Mesalazine—Crohn's disease	0.000641	0.00321	CcSEcCtD
Ezetimibe—Thrombocytopenia—Mesalazine—Crohn's disease	0.00064	0.0032	CcSEcCtD
Ezetimibe—Skin disorder—Mesalazine—Crohn's disease	0.000635	0.00318	CcSEcCtD
Ezetimibe—ABCB1—epithelium—Crohn's disease	0.00063	0.00285	CbGeAlD
Ezetimibe—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00062	0.00311	CcSEcCtD
Ezetimibe—Muscular weakness—Prednisone—Crohn's disease	0.00062	0.00311	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000619	0.0031	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000618	0.0147	CbGpPWpGaD
Ezetimibe—Pancreatitis—Prednisone—Crohn's disease	0.000596	0.00298	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000595	0.00298	CcSEcCtD
Ezetimibe—Feeling abnormal—Azathioprine—Crohn's disease	0.000591	0.00296	CcSEcCtD
Ezetimibe—Insomnia—Mesalazine—Crohn's disease	0.000591	0.00296	CcSEcCtD
Ezetimibe—Paraesthesia—Mesalazine—Crohn's disease	0.000587	0.00294	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000586	0.00294	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000586	0.014	CbGpPWpGaD
Ezetimibe—Dyspnoea—Mesalazine—Crohn's disease	0.000582	0.00292	CcSEcCtD
Ezetimibe—Dyspepsia—Mesalazine—Crohn's disease	0.000575	0.00288	CcSEcCtD
Ezetimibe—Decreased appetite—Mesalazine—Crohn's disease	0.000568	0.00284	CcSEcCtD
Ezetimibe—Abdominal pain—Azathioprine—Crohn's disease	0.000567	0.00284	CcSEcCtD
Ezetimibe—Body temperature increased—Azathioprine—Crohn's disease	0.000567	0.00284	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000564	0.00282	CcSEcCtD
Ezetimibe—Fatigue—Mesalazine—Crohn's disease	0.000563	0.00282	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000561	0.0134	CbGpPWpGaD
Ezetimibe—Erectile dysfunction—Prednisone—Crohn's disease	0.00056	0.0028	CcSEcCtD
Ezetimibe—Pain—Mesalazine—Crohn's disease	0.000559	0.0028	CcSEcCtD
Ezetimibe—Constipation—Mesalazine—Crohn's disease	0.000559	0.0028	CcSEcCtD
Ezetimibe—ABCG2—lymph node—Crohn's disease	0.000556	0.00251	CbGeAlD
Ezetimibe—SLCO1B1—Transport of organic anions—ALB—Crohn's disease	0.000549	0.0131	CbGpPWpGaD
Ezetimibe—ABCB1—mammalian vulva—Crohn's disease	0.000547	0.00247	CbGeAlD
Ezetimibe—ABCC3—Recycling of bile acids and salts—ALB—Crohn's disease	0.000547	0.013	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000546	0.013	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Mesalazine—Crohn's disease	0.000538	0.0027	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000534	0.00268	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Prednisone—Crohn's disease	0.000531	0.00266	CcSEcCtD
Ezetimibe—Hypersensitivity—Azathioprine—Crohn's disease	0.000528	0.00265	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000525	0.0125	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000525	0.0125	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000519	0.0124	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000519	0.0124	CbGpPWpGaD
Ezetimibe—Urticaria—Mesalazine—Crohn's disease	0.000519	0.0026	CcSEcCtD
Ezetimibe—Abdominal pain—Mesalazine—Crohn's disease	0.000516	0.00259	CcSEcCtD
Ezetimibe—Body temperature increased—Mesalazine—Crohn's disease	0.000516	0.00259	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.0005	0.0119	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.0005	0.0119	CbGpPWpGaD
Ezetimibe—Diarrhoea—Azathioprine—Crohn's disease	0.000491	0.00246	CcSEcCtD
Ezetimibe—ABCB1—lymphoid tissue—Crohn's disease	0.000486	0.00219	CbGeAlD
Ezetimibe—Hypersensitivity—Mesalazine—Crohn's disease	0.000481	0.00241	CcSEcCtD
Ezetimibe—ABCB1—digestive system—Crohn's disease	0.00048	0.00217	CbGeAlD
Ezetimibe—Connective tissue disorder—Prednisone—Crohn's disease	0.000478	0.00239	CcSEcCtD
Ezetimibe—Dizziness—Azathioprine—Crohn's disease	0.000474	0.00238	CcSEcCtD
Ezetimibe—Asthenia—Mesalazine—Crohn's disease	0.000469	0.00235	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—CD4—Crohn's disease	0.000463	0.011	CbGpPWpGaD
Ezetimibe—Pruritus—Mesalazine—Crohn's disease	0.000462	0.00231	CcSEcCtD
Ezetimibe—ANPEP—C-MYB transcription factor network—PTGS2—Crohn's disease	0.00046	0.011	CbGpPWpGaD
Ezetimibe—Vomiting—Azathioprine—Crohn's disease	0.000456	0.00228	CcSEcCtD
Ezetimibe—Rash—Azathioprine—Crohn's disease	0.000452	0.00226	CcSEcCtD
Ezetimibe—Dermatitis—Azathioprine—Crohn's disease	0.000452	0.00226	CcSEcCtD
Ezetimibe—Flushing—Prednisone—Crohn's disease	0.000452	0.00226	CcSEcCtD
Ezetimibe—Headache—Azathioprine—Crohn's disease	0.000449	0.00225	CcSEcCtD
Ezetimibe—Diarrhoea—Mesalazine—Crohn's disease	0.000447	0.00224	CcSEcCtD
Ezetimibe—Angiopathy—Prednisone—Crohn's disease	0.000441	0.00221	CcSEcCtD
Ezetimibe—Immune system disorder—Prednisone—Crohn's disease	0.000439	0.0022	CcSEcCtD
Ezetimibe—Dizziness—Mesalazine—Crohn's disease	0.000432	0.00216	CcSEcCtD
Ezetimibe—Alopecia—Prednisone—Crohn's disease	0.00043	0.00215	CcSEcCtD
Ezetimibe—Mental disorder—Prednisone—Crohn's disease	0.000426	0.00213	CcSEcCtD
Ezetimibe—Nausea—Azathioprine—Crohn's disease	0.000426	0.00213	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000425	0.0101	CbGpPWpGaD
Ezetimibe—Erythema—Prednisone—Crohn's disease	0.000424	0.00212	CcSEcCtD
Ezetimibe—Malnutrition—Prednisone—Crohn's disease	0.000424	0.00212	CcSEcCtD
Ezetimibe—Vomiting—Mesalazine—Crohn's disease	0.000415	0.00208	CcSEcCtD
Ezetimibe—Rash—Mesalazine—Crohn's disease	0.000412	0.00206	CcSEcCtD
Ezetimibe—Dermatitis—Mesalazine—Crohn's disease	0.000412	0.00206	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000409	0.00976	CbGpPWpGaD
Ezetimibe—Headache—Mesalazine—Crohn's disease	0.000409	0.00205	CcSEcCtD
Ezetimibe—SLCO1B1—Recycling of bile acids and salts—ALB—Crohn's disease	0.000407	0.00971	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000405	0.00966	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000398	0.00949	CbGpPWpGaD
Ezetimibe—Ill-defined disorder—Prednisone—Crohn's disease	0.000393	0.00197	CcSEcCtD
Ezetimibe—Anaemia—Prednisone—Crohn's disease	0.000391	0.00196	CcSEcCtD
Ezetimibe—Nausea—Mesalazine—Crohn's disease	0.000388	0.00194	CcSEcCtD
Ezetimibe—Angioedema—Prednisone—Crohn's disease	0.000387	0.00194	CcSEcCtD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000383	0.00914	CbGpPWpGaD
Ezetimibe—Malaise—Prednisone—Crohn's disease	0.000382	0.00191	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—PLA2G4F—Crohn's disease	0.000377	0.00899	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000366	0.00872	CbGpPWpGaD
Ezetimibe—Hypertension—Prednisone—Crohn's disease	0.000366	0.00183	CcSEcCtD
Ezetimibe—Arthralgia—Prednisone—Crohn's disease	0.000361	0.00181	CcSEcCtD
Ezetimibe—Myalgia—Prednisone—Crohn's disease	0.000361	0.00181	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000358	0.00179	CcSEcCtD
Ezetimibe—Discomfort—Prednisone—Crohn's disease	0.000356	0.00178	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000352	0.00839	CbGpPWpGaD
Ezetimibe—Anaphylactic shock—Prednisone—Crohn's disease	0.000346	0.00173	CcSEcCtD
Ezetimibe—Infection—Prednisone—Crohn's disease	0.000343	0.00172	CcSEcCtD
Ezetimibe—Nervous system disorder—Prednisone—Crohn's disease	0.000339	0.0017	CcSEcCtD
Ezetimibe—Skin disorder—Prednisone—Crohn's disease	0.000336	0.00168	CcSEcCtD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000323	0.00771	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—MTMR3—Crohn's disease	0.000321	0.00765	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000315	0.00158	CcSEcCtD
Ezetimibe—Insomnia—Prednisone—Crohn's disease	0.000313	0.00157	CcSEcCtD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000311	0.00742	CbGpPWpGaD
Ezetimibe—Paraesthesia—Prednisone—Crohn's disease	0.00031	0.00155	CcSEcCtD
Ezetimibe—UGT1A3—Metapathway biotransformation—GPX4—Crohn's disease	0.000309	0.00736	CbGpPWpGaD
Ezetimibe—Dyspepsia—Prednisone—Crohn's disease	0.000304	0.00152	CcSEcCtD
Ezetimibe—Decreased appetite—Prednisone—Crohn's disease	0.0003	0.0015	CcSEcCtD
Ezetimibe—Fatigue—Prednisone—Crohn's disease	0.000298	0.00149	CcSEcCtD
Ezetimibe—Constipation—Prednisone—Crohn's disease	0.000296	0.00148	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—PLA2G4F—Crohn's disease	0.000286	0.00682	CbGpPWpGaD
Ezetimibe—ABCC3—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000286	0.00681	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Prednisone—Crohn's disease	0.000285	0.00143	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Prednisone—Crohn's disease	0.000283	0.00142	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—PLA2G4F—Crohn's disease	0.000275	0.00656	CbGpPWpGaD
Ezetimibe—Urticaria—Prednisone—Crohn's disease	0.000275	0.00138	CcSEcCtD
Ezetimibe—ABCB1—lymph node—Crohn's disease	0.000274	0.00124	CbGeAlD
Ezetimibe—Abdominal pain—Prednisone—Crohn's disease	0.000273	0.00137	CcSEcCtD
Ezetimibe—Body temperature increased—Prednisone—Crohn's disease	0.000273	0.00137	CcSEcCtD
Ezetimibe—UGT2B7—Metapathway biotransformation—GPX4—Crohn's disease	0.000262	0.00626	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Prednisone—Crohn's disease	0.000255	0.00128	CcSEcCtD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000252	0.00601	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—FADS1—Crohn's disease	0.00025	0.00596	CbGpPWpGaD
Ezetimibe—Asthenia—Prednisone—Crohn's disease	0.000248	0.00124	CcSEcCtD
Ezetimibe—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000247	0.00589	CbGpPWpGaD
Ezetimibe—Pruritus—Prednisone—Crohn's disease	0.000245	0.00122	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—MTMR3—Crohn's disease	0.000243	0.0058	CbGpPWpGaD
Ezetimibe—Diarrhoea—Prednisone—Crohn's disease	0.000237	0.00118	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—GPX4—Crohn's disease	0.000234	0.00558	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—MTMR3—Crohn's disease	0.000234	0.00558	CbGpPWpGaD
Ezetimibe—Dizziness—Prednisone—Crohn's disease	0.000229	0.00114	CcSEcCtD
Ezetimibe—NPC1L1—Metabolism—GCKR—Crohn's disease	0.000226	0.00539	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000225	0.00536	CbGpPWpGaD
Ezetimibe—Vomiting—Prednisone—Crohn's disease	0.00022	0.0011	CcSEcCtD
Ezetimibe—Rash—Prednisone—Crohn's disease	0.000218	0.00109	CcSEcCtD
Ezetimibe—Dermatitis—Prednisone—Crohn's disease	0.000218	0.00109	CcSEcCtD
Ezetimibe—Headache—Prednisone—Crohn's disease	0.000217	0.00108	CcSEcCtD
Ezetimibe—UGT1A1—Metapathway biotransformation—GPX4—Crohn's disease	0.000213	0.00508	CbGpPWpGaD
Ezetimibe—SLCO1B1—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000213	0.00507	CbGpPWpGaD
Ezetimibe—Nausea—Prednisone—Crohn's disease	0.000205	0.00103	CcSEcCtD
Ezetimibe—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—Crohn's disease	0.000204	0.00486	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000195	0.00465	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000195	0.00465	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—FADS1—Crohn's disease	0.000189	0.00452	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—FADS1—Crohn's disease	0.000182	0.00435	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000181	0.00432	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GPX4—Crohn's disease	0.000177	0.00423	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000174	0.00415	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—GCKR—Crohn's disease	0.000171	0.00408	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GPX4—Crohn's disease	0.000171	0.00407	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GCKR—Crohn's disease	0.000165	0.00393	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000165	0.00393	CbGpPWpGaD
Ezetimibe—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000163	0.00389	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000162	0.00385	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PLA2G4F—Crohn's disease	0.000161	0.00384	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000155	0.0037	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000141	0.00337	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00014	0.00334	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000137	0.00328	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—MTMR3—Crohn's disease	0.000137	0.00326	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000137	0.00326	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000133	0.00317	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000133	0.00317	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.00013	0.00309	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000123	0.00292	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000122	0.00292	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000122	0.0029	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000121	0.00287	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000118	0.00281	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000116	0.00277	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000113	0.00269	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000112	0.00267	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000109	0.0026	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000107	0.00255	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—FADS1—Crohn's disease	0.000107	0.00254	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000106	0.00252	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000106	0.00252	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000104	0.00249	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000103	0.00246	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000102	0.00244	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GPX4—Crohn's disease	9.99e-05	0.00238	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.91e-05	0.00236	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.91e-05	0.00236	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	9.8e-05	0.00234	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GCKR—Crohn's disease	9.65e-05	0.0023	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.38e-05	0.00224	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	9.18e-05	0.00219	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	9.18e-05	0.00219	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL10—Crohn's disease	8.81e-05	0.0021	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PLA2G4F—Crohn's disease	8.63e-05	0.00206	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—CXCL8—Crohn's disease	8.34e-05	0.00199	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.29e-05	0.00198	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	8.12e-05	0.00194	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	7.86e-05	0.00187	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	7.61e-05	0.00181	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.44e-05	0.00177	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—MTMR3—Crohn's disease	7.33e-05	0.00175	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PLA2G4F—Crohn's disease	7.33e-05	0.00175	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PLA2G4F—Crohn's disease	7.33e-05	0.00175	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ALB—Crohn's disease	7.19e-05	0.00171	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.99e-05	0.00167	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.57e-05	0.00157	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—GCKR—Crohn's disease	6.47e-05	0.00154	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—PTGS2—Crohn's disease	6.29e-05	0.0015	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—MTMR3—Crohn's disease	6.24e-05	0.00149	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—MTMR3—Crohn's disease	6.24e-05	0.00149	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.18e-05	0.00147	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	6.03e-05	0.00144	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PLA2G4F—Crohn's disease	5.96e-05	0.00142	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.72e-05	0.00136	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—FADS1—Crohn's disease	5.71e-05	0.00136	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	5.53e-05	0.00132	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PLA2G4F—Crohn's disease	5.46e-05	0.0013	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ALB—Crohn's disease	5.45e-05	0.0013	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GPX4—Crohn's disease	5.35e-05	0.00128	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ALB—Crohn's disease	5.25e-05	0.00125	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IFNG—Crohn's disease	5.18e-05	0.00124	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GCKR—Crohn's disease	5.17e-05	0.00123	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—MTMR3—Crohn's disease	5.07e-05	0.00121	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PLA2G4F—Crohn's disease	5.06e-05	0.00121	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	4.96e-05	0.00118	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	4.96e-05	0.00118	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—FADS1—Crohn's disease	4.86e-05	0.00116	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—FADS1—Crohn's disease	4.86e-05	0.00116	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	4.82e-05	0.00115	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—PTGS2—Crohn's disease	4.77e-05	0.00114	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—MTMR3—Crohn's disease	4.64e-05	0.00111	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL1B—Crohn's disease	4.62e-05	0.0011	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—PTGS2—Crohn's disease	4.59e-05	0.00109	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GPX4—Crohn's disease	4.55e-05	0.00108	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GPX4—Crohn's disease	4.55e-05	0.00108	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GCKR—Crohn's disease	4.39e-05	0.00105	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GCKR—Crohn's disease	4.39e-05	0.00105	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.38e-05	0.00104	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—MTMR3—Crohn's disease	4.3e-05	0.00103	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—FADS1—Crohn's disease	3.95e-05	0.000941	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GPX4—Crohn's disease	3.7e-05	0.000881	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—FADS1—Crohn's disease	3.62e-05	0.000863	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GCKR—Crohn's disease	3.57e-05	0.000851	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	3.5e-05	0.000834	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GPX4—Crohn's disease	3.39e-05	0.000808	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—Crohn's disease	3.35e-05	0.0008	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—FADS1—Crohn's disease	3.35e-05	0.000799	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GCKR—Crohn's disease	3.27e-05	0.00078	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	3.14e-05	0.000749	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GPX4—Crohn's disease	3.14e-05	0.000748	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	3.09e-05	0.000737	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALB—Crohn's disease	3.07e-05	0.000732	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GCKR—Crohn's disease	3.03e-05	0.000722	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—Crohn's disease	2.99e-05	0.000712	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.75e-05	0.000655	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PLA2G4F—Crohn's disease	2.73e-05	0.000652	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—PTGS2—Crohn's disease	2.69e-05	0.00064	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	2.45e-05	0.000585	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.37e-05	0.000564	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.34e-05	0.000557	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—MTMR3—Crohn's disease	2.32e-05	0.000554	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.22e-05	0.00053	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.06e-05	0.000491	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.05e-05	0.000488	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—FADS1—Crohn's disease	1.81e-05	0.000432	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GPX4—Crohn's disease	1.7e-05	0.000404	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.68e-05	0.000402	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.66e-05	0.000395	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—Crohn's disease	1.64e-05	0.000392	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCKR—Crohn's disease	1.64e-05	0.000391	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—PTGS2—Crohn's disease	1.44e-05	0.000343	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.43e-05	0.000341	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—Crohn's disease	1.4e-05	0.000333	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—Crohn's disease	1.4e-05	0.000333	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—PTGS2—Crohn's disease	1.22e-05	0.000292	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—PTGS2—Crohn's disease	1.22e-05	0.000292	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—Crohn's disease	1.14e-05	0.000271	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—FADS1—Crohn's disease	1.12e-05	0.000266	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.11e-05	0.000265	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GPX4—Crohn's disease	1.04e-05	0.000249	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—Crohn's disease	1.04e-05	0.000248	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCKR—Crohn's disease	1.01e-05	0.000241	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—PTGS2—Crohn's disease	9.94e-06	0.000237	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—Crohn's disease	9.64e-06	0.00023	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—PTGS2—Crohn's disease	9.11e-06	0.000217	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—PTGS2—Crohn's disease	8.44e-06	0.000201	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—Crohn's disease	5.21e-06	0.000124	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—PTGS2—Crohn's disease	4.56e-06	0.000109	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—Crohn's disease	3.21e-06	7.66e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.81e-06	6.7e-05	CbGpPWpGaD
